Genedrive is a pharmacogenetic testing company that develops and commercializes rapid and simple point-of-care diagnostic platforms for the diagnosis of genetic variants. The company's core business is focused on providing personalized medicine solutions, enabling healthcare professionals to deliver tailored treatment plans based on an individual's genetic profile. Genedrive's flagship products include the Genedrive MT-RNR1 ID Kit for personalized antibiotic treatment and the Genedrive CYP2C19 ID Kit for personalized antiplatelet treatment, both of which have been developed and validated in collaboration with NHS partners. The company's molecular diagnostic platform aims to improve patient outcomes by providing rapid and accurate genetic testing results, allowing for more effective and targeted treatment plans.